argenx SE reported $288.02M in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
AstraZeneca USD 3.51B 1.3B Jun/2025
Galapagos EUR -57027000 101.68M Jun/2025
Genmab DKK 432M 900.27M Jun/2025
GlaxoSmithKline GBP 2.07B 462M Jun/2025
GRIFOLS EUR 331.94M 57.97M Jun/2025
Hikma Pharmaceutical USD 317M 85M Dec/2024
Qiagen NV USD 134.43M 9.77M Jun/2025
UCB EUR 502M 168M Dec/2024